(Q68411912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

author name string

C V Viner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

P J Selby

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

G B Zulian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

M E Gore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

M E Butcher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

C M Wootton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

T J McElwain

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

24 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

449-453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00686058

24 September 2019

exact match

0 references

cites work

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

1 reference

12 December 2020

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

12 December 2020

High-dose melphalan and autologous bone marrow transplant as treatment for refractory Hodgkin's disease

1 reference

12 December 2020

Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy

1 reference

12 December 2020

Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatin

1 reference

12 December 2020

Multiple myeloma treated with high dose intravenous melphalan

1 reference

12 December 2020

Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist.

1 reference

12 December 2020

Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission

1 reference

12 December 2020

The efficacy of GR38032F, an antagonist of 5-hydroxytryptamine-3 (5-HT3) in the prophylaxis of cisplatin (CDDP)-induced nausea and vomiting

1 reference

12 December 2020

High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma

1 reference

12 December 2020

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686058

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2138064%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference